QDEL's strong product portfolio raises optimism about the stock.

PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.

NARI continues to gain from its expanded product portfolio. However, continued loss at the operating level raises concern.

GKOS continues to benefit from a robust demand for its products as well as expansion in new markets. A strong development pipeline raises optimism.

GKOS continues to benefit from a robust demand for its products as well as expansion in new markets. A strong development pipeline raises optimism.

STE's strong prospects in the healthcare business arm bode well for investors.

CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.

Investors remain optimistic about Patterson Companies on the back of its broad product line.

Investors remain optimistic about Patterson Companies on the back of its broad product line.

TDY makes a strong case for investment in the aerospace sector, given its long-run growth prospects, low debt and strategic acquisitions.